Navigation Links
Jazz Pharmaceuticals Announces Development Timeline Updates
Date:6/11/2008

lexibility in our requirements for future financing and we believe will shorten our timeline to reach profitability," said Dr. Samuel Saks, the Chief Executive Officer of Jazz Pharmaceuticals. "We are actively seeking partners for several of our development programs. We have been pleased with the level of interest from potential partners and look forward to completing one or more development partnerships to help us bring these important therapies to the market as quickly as possible."

In connection with these strategic decisions, Jazz Pharmaceuticals will reduce its workforce by 33 employees (8 percent), primarily in research and development and administrative areas. The company expects to record a charge of approximately $0.5 million related to the workforce reduction in the second quarter of 2008.

About Jazz Pharmaceuticals, Inc.

Jazz Pharmaceuticals is a specialty pharmaceutical company focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry. For further information see http://www.JazzPharmaceuticals.com.

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995

This press release contains forward-looking statements, including, but not limited to, statements related to the continued development of Jazz Pharmaceuticals' development product candidates, the timing of clinical study activities, the completion or results of potential development partnerships and the estimated charge related to the workforce reduction. These forward- looking statements are based on the company's current expectations and inherently involve significant risks and uncertainties. Jazz Pharmaceuticals' actual results and the timing of events could differ materially from those anticipated in such forward looking statements as a result of these risks and uncertainties, which include, without limitat
'/>"/>

SOURCE Jazz Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
2. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
3. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
4. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
5. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
6. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
8. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
9. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
10. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
11. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... (PRWEB) July 28, 2014 The Oakwood ... Harris, Birkhill, Wang, Songe and Associates, PC that will ... countless tomorrows to come. , The HBWS group ... for more than $2.5 million in donations. Through their ... sponsors for the Oakwood Women’s Healthcare Classic for the ...
(Date:7/28/2014)... somethinglike the meal you,ve ordered at a restaurantor ... sweep through your brain. , These waves ... symphony of cellsboth excitatory and inhibitoryplaying together in ... debated, gamma waves have been associated with higher-level ... been tied to schizophrenia, Alzheimer,s disease, autism, epilepsy ...
(Date:7/28/2014)... HealthDay Reporter MONDAY, July 28, 2014 ... apnea in children, but a new study confirms that the ... already overweight. The researchers said that,s a concern, because ... problems -- including, ironically, sleep apnea. But they,re not advising ... said, doctors and parents should be aware that a healthy ...
(Date:7/28/2014)... 28, 2014 UT Southwestern Medical Center cancer ... irreversibly interferes with the activity of a mutated ... , The molecule, SML-8-73-1 (SML), interferes with the ... homolog. The gene produces proteins called K-Ras that ... result in normal cells dividing uncontrollably and turning ...
(Date:7/28/2014)... NJ (PRWEB) July 28, 2014 Lourdes ... provide enhanced access and reduced wait times for veterans ... six hospital systems in the state—and the only one ... Federal Services Patient-Centered Community Care program (PC3). PC3 gives ... Administration (VA) hospital cannot provide services due to lack ...
Breaking Medicine News(10 mins):Health News:Memory relies on astrocytes, the brain's lesser known cells 2Health News:Memory relies on astrocytes, the brain's lesser known cells 3Health News:Tonsillectomy for Sleep Apnea May Trigger Weight Gain 2Health News:Tonsillectomy for Sleep Apnea May Trigger Weight Gain 3Health News:UTSW cancer researchers identify irreversible inhibitor for KRAS gene mutation 2Health News:Lourdes Expands Military Partnership with Veterans 2Health News:Lourdes Expands Military Partnership with Veterans 3
... Centers for Disease Control and Prevention said that all samples ... to adamantanes, the class of drugs which is used for ... this class like amantadine and rimantadine are ineffectual for now ... ,The findings were reported in the Journal of the ...
... fluid protects the baby in the mother’s womb. A new ... proteins in the amniotic fluid doctors can predict the risk ... at risk of severe infections. // ,Dr Catalin ... using imaging mass spectrometry obtained the details of the proteins ...
... hit by AIDS. But now after bringing in changes in their ... initial sex // and using condoms have greatly reduced the number ... was found that among women in the age group of 15-24 ... witnessed among men in the age group of 17-29. ...
... W. Bush as called for complete banning on human cloning ... to reduce the medical // liability system; the President is ... American people which has reduced the number of abortions and ... urged the congress to approve a complete ban on human ...
... peninsula. A new case of a 15-year-old boy who tested positive ... Indonesian town of Bandung.// , ,In case the local results ... will become the 15th human fatality from bird flu in Indonesia., ... regency, some150 km south of Jakarta. He was admitted to the ...
... has revealed that 90 percent of the drugs administered to ... morphine, // thyrozine, the thyroid drug and even some anti-epileptic ... there was no valid license for doing so, the report ... high-risk medications like asthma inhalers have also never been tried ...
Cached Medicine News:Health News:Resistant Influenza strains creates panic in US 2
(Date:7/28/2014)... YORK , July 28, 2014 ... is available in its catalogue: ... http://www.reportlinker.com/p0207141/Portugal-Pharmaceuticals-and-Healthcare-Report-Q3-2014.html ... BMI View: Faster-than-expected economic growth last quarter ... pharmaceutical forecasts slightly upwards. As forecast previously, BMI ...
(Date:7/28/2014)... LEHIGH VALLEY, Pa. , July 28, 2014 /PRNewswire/ ... a reliable, uninterrupted supply of medical oxygen is vital ... company to technical innovations that not only improve the ... gas use. Air Products will highlight these systems—including systems ... systems that reduce oxygen loss—from August 4-5 at the ...
(Date:7/28/2014)... , July 28, 2014 Southern Research ... , Ph.D., President and CEO of Southern Research ... Release Society (CRS) for the 2014-2015 term.  The ... on July 12 in Chicago ... The Controlled Release Society is ...
Breaking Medicine Technology:Portugal Pharmaceuticals and Healthcare Report Q3 2014 2Portugal Pharmaceuticals and Healthcare Report Q3 2014 3Portugal Pharmaceuticals and Healthcare Report Q3 2014 4Air Products Highlights Its Medical Oxygen Supply Systems for Emergency Oxygen Supply and Reduced Oxygen Loss at ASHE 2Air Products Highlights Its Medical Oxygen Supply Systems for Emergency Oxygen Supply and Reduced Oxygen Loss at ASHE 3Arthur J. Tipton, Ph.D., Named President of Controlled Release Society 2Arthur J. Tipton, Ph.D., Named President of Controlled Release Society 3
... RICHMOND, Calif. , Jan. 27 Sangamo BioSciences, Inc. (Nasdaq: ... quarter and full year 2009 financial results on Wednesday, February 3, ... by a conference call at 5:00 p.m. ET , which will ... call, the company will review the financial results and discuss other business ...
... LAKES, N.J. , Jan. 27 BD (Becton, Dickinson ... technology company, is increasing the supply of its products available for ... the $500,000 announced on January 15 to ...  This additional commitment will help BD,s nonprofit partner organizations use and ...
Cached Medicine Technology:Sangamo BioSciences Announces Fourth Quarter and Full Year 2009 Conference Call and Webcast 2BD Increases Haiti Relief Fund to Include $5 Million in Product Donations 2BD Increases Haiti Relief Fund to Include $5 Million in Product Donations 3
Sealing Mat for 96-well, 2.0ml, Deep Well, Square Available Sterile...
Sealing Mat for 96-well PCR Plate, Natural...
96-well Silicone Expansion Mat, Bulk...
... use with the Moto Alpha unit, these new pads ... in which several successive runs may be sealed with ... is engineered to prevent a microplate from sticking to ... an improved level of sealing performance, which means you ...
Medicine Products: